Clinical Decline News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Decline. Real-time updates on events, politics, business and more.

Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint - Biogen (NASDAQ:BIIB) - Press Release

September 28, 2022

Showing Highly Statistically Significant Reduction of Clinical Decline in Large Global Clinical Study of 1,795 Participants With Early Alzheimer's Dis

Eisai Co Ltd Clinical Trials On Alzheimer Congress Biogen Inc Clinical Decline Large Global Clinical Study With Early Alzheimer

Source: wiredprnews.com

Biogen Inc.: Biogen to Present New Research at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

March 11, 2022

CAMBRIDGE, Mass., March 11, 2022(Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, as well as data for ADUHELM (aducanumab-avwa) injection 100 mg/mL for intravenous use

United Kingdom Comunidad Autonoma De Cataluna Ashleigh Koss Mike Hencke Walter Gilbert Charles Weissmann

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Clinical Decline News Today

Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint - Biogen (NASDAQ:BIIB) - Press Release

Biogen Inc.: Biogen to Present New Research at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

Explore More Categories